Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Sloan

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2018
Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain AmyloidosisVina P Nguyen, Heather Landau, Karen Quillen, et al.
Haematologica|October 11, 2015
Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosisKatherine M Bever, Luke I Masha, Fangui Sun, et al.
JAMA Network Open|September 11, 2024
Cancer Trial Eligibility and Therapy Modifications for Individuals With Duffy Null-Associated Neutrophil CountStephen P Hibbs, Laura Aiken, Kruti Vora, et al.
Kidney Medicine|August 1, 2020
Monoclonal IgG4/2κ Deposition Following Eculizumab Therapy for Recurrent Atypical Hemolytic Uremic Syndrome in Kidney TransplantationPriyamvada Singh, Hui Chen, Craig E Gordon, et al.
Advances in Hematology|March 19, 2024
The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 PatientsRena Zheng, Alexandra Solomon, Madeline DiLorenzo, et al.
American Journal of Clinical Pathology|July 19, 2020
SARS-CoV-2 Infection-Associated Hemophagocytic LymphohistiocytosisAndrey Prilutskiy, Michael Kritselis, Artem Shevtsov, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 27, 2025
When ICAN(S) Becomes ICAN'T: Clinician and Staff Perspectives on In-Hospital Neurotoxicity GradingGrace M Ferri, Allison Frank, Daniel Li, et al.
Journal of Medical Internet Research|August 9, 2022
Usability Evaluation of a Noninvasive Neutropenia Screening Device (PointCheck) for Patients Undergoing Cancer Chemotherapy: Mixed Methods Observational StudyGanimete Lamaj, Alberto Pablo-Trinidad, Ian Butterworth, et al.
Blood|August 11, 2011
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patientsMaria Teresa Cibeira, Vaishali Sanchorawala, David C Seldin, et al.
American Journal of Hematology|June 22, 2022
Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal studyJoshua N Gustine, Andrew Staron, Raphael E Szalat, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2018
Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain AmyloidosisVina P Nguyen, Heather Landau, Karen Quillen, et al.
Haematologica|October 11, 2015
Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosisKatherine M Bever, Luke I Masha, Fangui Sun, et al.
JAMA Network Open|September 11, 2024
Cancer Trial Eligibility and Therapy Modifications for Individuals With Duffy Null-Associated Neutrophil CountStephen P Hibbs, Laura Aiken, Kruti Vora, et al.
Kidney Medicine|August 1, 2020
Monoclonal IgG4/2κ Deposition Following Eculizumab Therapy for Recurrent Atypical Hemolytic Uremic Syndrome in Kidney TransplantationPriyamvada Singh, Hui Chen, Craig E Gordon, et al.
Advances in Hematology|March 19, 2024
The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 PatientsRena Zheng, Alexandra Solomon, Madeline DiLorenzo, et al.
American Journal of Clinical Pathology|July 19, 2020
SARS-CoV-2 Infection-Associated Hemophagocytic LymphohistiocytosisAndrey Prilutskiy, Michael Kritselis, Artem Shevtsov, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 27, 2025
When ICAN(S) Becomes ICAN'T: Clinician and Staff Perspectives on In-Hospital Neurotoxicity GradingGrace M Ferri, Allison Frank, Daniel Li, et al.
Journal of Medical Internet Research|August 9, 2022
Usability Evaluation of a Noninvasive Neutropenia Screening Device (PointCheck) for Patients Undergoing Cancer Chemotherapy: Mixed Methods Observational StudyGanimete Lamaj, Alberto Pablo-Trinidad, Ian Butterworth, et al.
Blood|August 11, 2011
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patientsMaria Teresa Cibeira, Vaishali Sanchorawala, David C Seldin, et al.
American Journal of Hematology|June 22, 2022
Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal studyJoshua N Gustine, Andrew Staron, Raphael E Szalat, et al.
Pageof 7